ESC Premium Access

Improvement in FFR predicts 2 years outcome after PCI. A FAME 2 Sub-Analysis.

Congress Presentation

About the speaker

Doctor Stephane Fournier

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)
5 presentations
0 follower

5 more presentations in this session

The Bivalirudin versus Heparin in non-ST and ST-segment elevation myocardial infarction in patients on modern antiplatelet therapy in SWEDEHEART

Speaker: Professor D. Erlinge (Lund, SE)


Efficacy and Safety of a Pharmaco-Invasive Strategy versus Primary Angioplasty in ST-Elevation Myocardial Infarction: The EARLY-MYO Trial

Speaker: Professor B. HE (Shanghai, CN)


Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes - TROPICAL-ACS - Trial

Speaker: Professor D. Sibbing (Munich, DE)


RE-DUAL PCI : Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation

Speaker: Professor C. Cannon (Boston, US)


Have we reached the bottom line in mortality after Acute Myocardial Infarction? Changes over 20 years in patient characteristics, management, and 6-month outcomes in the FAST-MI programme: 1995-2015

Speaker: Professor N. Danchin (Paris, FR)


Access the full session

Late-Breaking Science in PCI 2

Speakers: Doctor S. Fournier, Professor D. Erlinge, Professor B. HE, Professor D. Sibbing, Professor C. Cannon...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb